TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens

Rashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi, Nicholas J. Short, Guilin Tang, Ghayas C. Issa, Farhad Ravandi, Guillermo Garcia-Manero, Cameron C. Yin, Rajyalakshmi Luthra, Keyur P. Patel, Joseph D. Khoury, Guillermo Montalban-Bravo, Koji Sasaki, Tapan M. Kadia, Gautam Borthakur, Marina Konopleva, Nitin Jain, Rebecca Garris, Sherry PierceWilliam Wierda, Zeev Estrov, Jorge Cortes, Susan O'Brien, Hagop M. Kantarjian, Elias Jabbour

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens'. Together they form a unique fingerprint.

Medicine & Life Sciences